Annual Cash & Cash Equivalents
$83.13 M
+$8.90 M+11.98%
December 31, 2023
Summary
- As of February 7, 2025, AKYA annual cash & cash equivalents is $83.13 million, with the most recent change of +$8.90 million (+11.98%) on December 31, 2023.
- During the last 3 years, AKYA annual cash & cash equivalents has risen by +$66.12 million (+388.80%).
- AKYA annual cash & cash equivalents is now -26.49% below its all-time high of $113.08 million, reached on December 31, 2021.
Performance
AKYA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.56 M
+$3.63 M+40.73%
September 30, 2024
Summary
- As of February 7, 2025, AKYA quarterly cash and cash equivalents is $12.56 million, with the most recent change of +$3.63 million (+40.73%) on September 30, 2024.
- Over the past year, AKYA quarterly cash and cash equivalents has dropped by -$66.04 million (-84.02%).
- AKYA quarterly cash and cash equivalents is now -90.73% below its all-time high of $135.46 million, reached on June 30, 2021.
Performance
AKYA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AKYA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.0% | -84.0% |
| 3 y3 years | +388.8% | -89.5% |
| 5 y5 years | +614.4% | -89.5% |
AKYA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.5% | +12.0% | -88.9% | +40.7% |
| 5 y | 5-year | -26.5% | +614.4% | -90.7% | +40.7% |
| alltime | all time | -26.5% | +614.4% | -90.7% | +40.7% |
Akoya Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.56 M(+40.7%) |
| Jun 2024 | - | $8.92 M(-31.6%) |
| Mar 2024 | - | $13.04 M(-84.3%) |
| Dec 2023 | $83.13 M(+12.0%) | $83.13 M(+5.8%) |
| Sep 2023 | - | $78.59 M(-15.8%) |
| Jun 2023 | - | $93.33 M(+54.9%) |
| Mar 2023 | - | $60.25 M(-18.8%) |
| Dec 2022 | $74.23 M | $74.23 M(+43.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $51.84 M(+10.6%) |
| Jun 2022 | - | $46.88 M(-50.1%) |
| Mar 2022 | - | $93.94 M(-16.9%) |
| Dec 2021 | $113.08 M(+564.9%) | $113.08 M(-5.9%) |
| Sep 2021 | - | $120.15 M(-11.3%) |
| Jun 2021 | - | $135.46 M(+1058.7%) |
| Mar 2021 | - | $11.69 M(-31.3%) |
| Dec 2020 | $17.01 M(+46.1%) | $17.01 M |
| Dec 2019 | $11.64 M | - |
FAQ
- What is Akoya Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Akoya Biosciences?
- What is Akoya Biosciences annual cash & cash equivalents year-on-year change?
- What is Akoya Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Akoya Biosciences?
- What is Akoya Biosciences quarterly cash and cash equivalents year-on-year change?
What is Akoya Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of AKYA is $83.13 M
What is the all time high annual cash & cash equivalents for Akoya Biosciences?
Akoya Biosciences all-time high annual cash & cash equivalents is $113.08 M
What is Akoya Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, AKYA annual cash & cash equivalents has changed by +$8.90 M (+11.98%)
What is Akoya Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AKYA is $12.56 M
What is the all time high quarterly cash and cash equivalents for Akoya Biosciences?
Akoya Biosciences all-time high quarterly cash and cash equivalents is $135.46 M
What is Akoya Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, AKYA quarterly cash and cash equivalents has changed by -$66.04 M (-84.02%)